Autologous Adipose Derived Stem Cells Transplantation in the Treatment of Keloids.

PHASE2CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

March 1, 2021

Primary Completion Date

June 16, 2021

Study Completion Date

June 16, 2021

Conditions
KeloidAutologus Adipose Derived Stem CellsFeasibilitySafety
Interventions
BIOLOGICAL

Autologous adipose derived stem cells

Once consented, tumescent liposuction will be performed and 100-300ml of lipoaspirate will be collected. The harvested lipoaspirate will be processed aseptically in theatre through centrifugation at 1200g, then the sediment will be washed with Phosphate buffered saline and then incubated at 37 degrees celsius in 0.075% Collagenase type 1a for 1 hour. This will then be washed in an equal volume of 10% Fetal Bovine Serum then filtered through a 100 micrometer cell strainer. Red cells lysed using the Red cell lysis buffer will be performed followed by washing in Phosphate buffered Saline and centrifugation and the stromal vascular fraction cell pellet collected and diluted into 5ml normal saline solution for immediate infiltration. cell counts and viability using Trypan blue will be perfomed prior to the infiltration

Trial Locations (1)

Unknown

Department of Surgery, Makerere University College of Health Sciences, Kampala

All Listed Sponsors
lead

Makerere University

OTHER

NCT04553159 - Autologous Adipose Derived Stem Cells Transplantation in the Treatment of Keloids. | Biotech Hunter | Biotech Hunter